In a nutshell Risk factors for Alzheimer’s disease are linked to cognitive function as early as ages 24-34, decades before ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

New research reveals that MRI distance measures may more accurately predict cognitive decline during the preclinical phase of ...

ESTHER study found that non-modifiable factors like age, sex, and APOE ε4 status significantly influence blood biomarker ...

Evidence shows that vaccines of shingles, even influenza and tuberculosis, can lower the incidence of the disease ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

Lifeforce, the world's leading longevity medicine program, has introduced the Lifeforce Brain Protection Program, a first-of-its-kind solution for people wanting to proactively take control of their ...

Abu Dhabi has taken a groundbreaking step in personalised healthcare by integrating APOE genetic testing for Alzheimer’s ...

In a large Swedish study, researchers found that the environmentally sustainable EAT-Lancet diet does not increase dementia ...

Leqembi gains European approval after CHMP reversal, despite safety concerns tied to brain swelling and bleeding in Alzheimer ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and ...

APOE ε4 is known to significantly raise ... In older adults, high levels of these proteins are often indicators of brain damage linked to Alzheimer’s. In young adults, elevated levels of ...